William N. (Bill) Anderson
Education
- Bachelor of Science degree - University of Texas
- Master of Science degree - Massachusetts Institute of Technology (MIT)
- Master of Science in Management - MIT’s Sloan School.
Overview
William N. (Bill) Anderson is a Chairman of the Board of Management (CEO) of Bayer AG.Inc.(BAYN). Bill started his professional career in 1989 at Ethyl Corporation, a U.S.-based specialty chemical company, with postings in Belgium and the Netherlands. In 1995, he joined Raychem Corporation, a U.S.-based material science and electronics firm. In 1997, Bill moved to Biogen, an American biotechnology firm, as a finance manager. He then became GM of the UK affiliate and eventually Vice President of Biogen’s Neurology Unit. Bill joined Genentech, a pioneering biotechnology company, in 2006, eventually serving as Senior Vice President of the firm’s oncology business.
In 2013, he joined Roche Pharmaceuticals, the parent company of Genentech, as Head of Global Product Strategy and Chief Marketing Officer. In 2016, he moved back to Genentech to assume the position of Head of North American Operations before becoming CEO of the company in 2017. In 2019, Bill became CEO of Roche Pharmaceuticals based in Switzerland.
Early Life
William N. (Bill) Anderson was born in 23 August 1966 .
Career
- BAYN - CEO
Recognition
2024 Best Lawyer in America